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ABSTRACT
Objectives Time series studies have shown adverse
effects of outdoor air pollution on mortality and hospital
admissions in patients with chronic obstructive
pulmonary disease (COPD) but panel studies have been
inconsistent. This study investigates short-term effects
of outdoor nitrogen dioxide, ozone, sulfur dioxide,
particulate matter (PM10) and black smoke on
exacerbations, respiratory symptoms and lung function in
94 patients with COPD in east London.
Methods Patients were recruited from an outpatient
clinic and were asked to complete daily diary cards
(median follow-up 518 days) recording exacerbations,
symptoms and lung function, and the amount of time
spent outdoors. Outdoor air pollution exposure (lag
1 day) was obtained from local background monitoring
stations.
Results Symptoms but not lung function showed
associations with raised pollution levels. Dyspnoea was
significantly associated with PM10 (increase in odds for
an IQR change in pollutant: 13% (95% CI 4% to 23%))
and this association remained after adjustment for other
the pollutants measured. An IQR increase in nitrogen
dioxide was associated with a 6% (0e13%) increase in
the odds of a symptomatic fall in peak flow rate. The
corresponding effect sizes for PM10 and black smoke
were 12% (2e25%) and 7% (1e13%), respectively.
Conclusion It is concluded that outdoor air pollution is
associated with important adverse effects on symptoms
in patients with COPD living in London.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is
increasing in incidence worldwide and is currently
the sixth leading cause of death.1 Patients with
COPD are prone to acute deterioration in their
chronic symptoms. These exacerbations of COPD
were ﬁrst shown to be associated with air pollut-
ants during the London smog episode of 1952.2
There is now clear evidence that air pollution at
current levels in London affects mortality3 4 and
that air pollution levels in Europe lead to hospital
admissions for COPD.5
Panel studies have shown adverse effects at
relatively low levels of pollution. One of the earliest
panel studies in patients with COPD showed that
changes in pollution level were associated with
exacerbations of chronic bronchitis.6 A study in
Merseyside, UK involving 75 patients with
COPD reported effects of ozone (O3) and sulfur
dioxide (SO2) on peak expiratory ﬂow (PEF) and
respiratory symptoms recorded daily using diary
cards.7 A Dutch panel study similarly reported
adverse effects of PM10 (particulate matter), black
smoke, sulfate and SO2 on PEF, and effects of black
smoke on upper respiratory symptoms in 326
symptomatic adults.8 A panel study in Italy
reported adverse effects of particles and nitrogen
dioxide (NO2) on forced vital capacity (FVC) and
forced expiroatory volume in 1 s (FEV1) in 29
subjects with COPD,9 and similar associations
between FEV1 and particles were reported in a US
COPD panel with 24 subjects.10 A New Zealand
COPD panel study in 48 patients found no effect of
pollution levels on PEF but observed effects of
particles on night-time symptoms and nebuliser
use.11 A French study conducted at a similar time to
the present study analysed effects of air pollution
on COPD exacerbations and reported adverse
effects of O3.12
In this paper we examine the effects of a range of
air pollutants on COPD exacerbations, respiratory
symptoms and respiratory function, including large
decrements in PEF, in a panel of 94 patients with
moderate to severe COPD selected from a COPD




The East London COPD study was established in
1995 as a prospective study of the role of viral
infections and environmental factors in COPD
exacerbations.13e16 Subjects were patients with
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moderate to severe COPD attending an outpatient clinic at the
London Chest Hospital, London. Recruitment was from October
1995 to October 1997. Inclusion criteria were: FEV1 <70%
predicted for age and height, b2-agonist reversibility <15% or
200 ml17 18 and no exacerbations in the previous 4 weeks.
Exclusion criteria were asthma, bronchiectasis, carcinoma of the
bronchus or inability to complete diary cards. Patients were seen
at the clinic monthly during the colder months and 3-monthly
during the rest of the year. Patients were also seen acutely at
exacerbation and then at a convalescent visit 4e6 weeks post-
exacerbation.
Data collected
At recruitment, baseline measurements were made of height,
weight, FEV1, FVC and PEF by rolling seal spirometer (Sensor
Medic, Yorba Linda, California, USA), reversibility to 400 mg of
inhaled salbutamol, and arterialised earlobe blood gases.19
Patients recorded symptoms and lung function daily on diary
cards. Patients measured PEF indoors after morning medication
using a Mini-Wright peak ﬂow meter (Clement Clarke Interna-
tional, Harlow, UK). They recorded any increase in chronic
symptoms during the previous 24 h. Symptoms were cate-
gorised as major (dyspnoea, sputum purulence, sputum amount)
or minor (nasal discharge/congestion, wheeze, sore throat,
cough). Patients recorded bedroom temperature on waking using
a 18C Thermax temperature strip (Thermographic Measure-
ments, Burton, UK). From March 1996 onwards, patients
recorded the number of hours spent outdoors. FEV1 and FVC
were also measured in a subsample of 28 patients using a hand-
held spirometer (Micro Medical, Rochester, UK). At the outset of
the study, patients were taught how to measure and record lung
function and symptoms, and were reminded and/or re-educated
when they visited the clinic.
Exacerbations
Patients were asked to attend clinic if their symptoms worsened.
Exacerbations were identiﬁed by symptoms recorded on the
diary cards or from the history when patients presented to the
physician (TAS), according to the criteria modiﬁed from
Anthonisen et al20 of any two major symptoms or one major and
two minor symptoms on two consecutive days.13 The ﬁrst of
the 2 days was taken as the onset of the exacerbation. Symp-
toms present continuously for >5 days prior to the possible
onset of an exacerbation were discounted. Patients experiencing
an exacerbation were given appropriate medication.
A less severe but more common form of exacerbation was also
deﬁned a priori as a fall in PEF of 10 l/min for $2 days plus
a reported increase in dyspnoea. This was termed a ‘symptom-
atic fall in PEF’. The rationale for using this is that patients with
COPD, particularly frequent exacerbators, have high psychoso-
cial and depression scores13; however, the presence of symptoms
together with a change in lung function is more suggestive of an
airway effect than psychological effects.
Outdoor air pollution data
Hourly measurements of NO2, O3, SO2 and PM10 were obtained
from the national air quality monitoring network station at
Bloomsbury Square, central London via the UK National Air
Quality Information Archive (http://www.airquality.co.uk/).
At the time of the study this was the only monitoring station in
London for these pollutants. The following pollutant measures
were derived: maximum hourly NO2, maximum 8 h moving
average O3, 24 hmean SO2 and PM10. The completeness criterion
was the availability of at least 75% of the data used to calculate
the summary measure for each day. The PM10 data from this
monitor are very closely correlated with the North Kensington
site data for the same period (r¼0.95) and so it was reasonable for
the Bloomsbury data to represent background levels. For black
smoke there was a network of monitors at that time (unlike for
other pollutants) and so we used 24 h average black smoke data
from the monitor nearest each patient’s home. Missing pollution
data were imputed using a standard method.21 We chose a priori
to analyse 1 day lags (previous day) for all pollutants based on the
results of time series studies available at the time.
Statistical methods
Brief details of statistical methods and rationale are given here,
but fuller details are given in the online supplement. Symptoms
and exacerbations were analysed as binary incidentsdthat is,
the ﬁrst day of an episode was the ‘event’. To distinguish
between new episodes of symptom worsening and the contin-
uation of a current episode, a new episode was recorded when
that symptom was not recorded in the previous 7 days.
Generalised estimating equations (GEEs) were used for anal-
ysis, taking account of variation within and between individ-
uals. Effects of each symptom or exacerbation were modelled
separately, with each pollutant level in turn as the main
explanatory variable. Control was made for daily temperature
(average of minimum and maximum) and season (analysed in
four groupsdspring, summer, autumn and winter), with esti-
mates of variance robust against misspeciﬁcation of correlation
structure, which was assumed to be independent. Results were
obtained as ORs and 95% CIs.
All lung function data (PEF, FEV1 and FVC) were analysed as
deviations from the individual mean to allow for variation
between individuals. Lung function data were analysed in three
ways. First they were analysed by season and year
(4 seasons32 years) to investigate seasonal effects, adjusting for
indoor temperature and time spent outdoors using methodology
described in previous reports.22 23 Secondly, they were analysed
using GEEs with Normal errors to summarise effects across the
entire time period. Analyses used a ﬁrst-order autoregressive
correlation structure and controlled for temperature and season
as described above for symptoms. In addition, a linear time term
was included to allow for decline in lung function. Thirdly, lung
function was analysed as a binary variable following the method
of Hoek.24 For each patient, an adverse event, ‘large peak ﬂow
decrement’, was deﬁned if lung function was >20% below that
individual’s median value. These binary events were also
modelled using GEEs as described above for the symptom data.
Some associations were observed for effects of single pollut-
ants on certain symptoms and so we decided post hoc to ﬁt
selected multipollutant models to try to disentangle these
effects and aid interpretation.
All effect estimates are presented in two ways: (1) repre-
senting a unit change in pollutant level (ppb or mg/m3 as
appropriate) and (2) scaled to an IQR change in that pollutant
level to aid interpretation. All analyses used Stata v11.
RESULTS
Summary statistics for subjects and exposure data
A total of 125 patients were recruited, of whom 31 were
excluded for the following reasons: not continuously resident in
London (13), in the study for <3 weeks (10), patient errors in
data recording (1), misplaced diary sheets (1), dementia (1),
asthma (1), precancerous illness (1), psychiatric disorder (1) and
died (2). Median duration of follow-up was 518 days (range
21e709). Shortened length of follow-up was due to either late
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recruitment, moving away or death. Fifteen patients had their
series of measurements truncated as it was suspected that use of
the measuring instrument was unreliable during the ﬁrst few
weeks. Further patient characteristics are reported in table 1 and
show that the series predominantly comprised older males with
obstructive lung disease. Mean numbers of symptoms over the
period varied considerably among individuals but were on
average quite low, suggesting that the condition of some
patients was reasonably stable. Mean values for pollutants were:
NO2 1 h max, 51.4 ppb; O3 8 h average, 15.5 ppb; SO2 24 h
average, 7.5 ppb; PM10 24 h average, 37.7 mg/m3; black smoke
24 h average, 10.1 mg/m3 (table 2). Data from eight different
black smoke monitors were used although the majority of
patients (63%) lived nearest to one monitor (Stepney), which
was close to the hospital.
Effects on lung function
When lung function was analysed by season, very few statisti-
cally signiﬁcant effects were observed. There was a signiﬁcant
adverse effect of O3 on PEF in summer 1996 but not in summer
1997. For FEV1, there was one signiﬁcant association for SO2 in
spring 1996 but this was not replicated the following year. For
FVC, signiﬁcant negative associations were observed for NO2,
PM10 and black smoke in summer 1996 and SO2 in spring 1996,
but none of these seasonal effects was replicated in 1997 (tables
E1eE3 in the online data supplement).
These non-signiﬁcant ﬁndings were conﬁrmed when lung
function was analysed over the 2 years combined (table 3). Most
regression coefﬁcients were positive not negative, and one (PEF
and NO2) was statistically signiﬁcant. There was no consistency
in ﬁndings for PEF, FEV1 and FVC, again providing no support
for any adverse effect of pollution on mean respiratory function
(table 3). There was no evidence for effects of any pollutant on
large PEF decrements (table 4), with all ORs close to 1.0 and
non-signiﬁcant.
Effects on exacerbations and symptoms
All ORs for effects of pollutants on exacerbations were >1.0,
suggesting adverse effects, but all were non-signiﬁcant (table 4).
Effect sizes were bigger for symptomatic fall in PEF where
PM10 and black smoke showed signiﬁcant adverse effects. The
remaining ORs for NO2, O3 and SO2, while not signiﬁcant, were
nonetheless consistently >1.0. ORs for a symptomatic fall in
PEF for a change in pollutant level equivalent to the IQR were
1.12 (95% CI 1.02 to 1.25, PM10) and 1.07 (1.01 to 1.13, black
smoke). Dyspnoea was signiﬁcantly associated with PM10 (OR
Table 1 Summary statistics for respiratory data October
1995eOctober 1997
n Mean (SD) or % Median Minimum Maximum
Male sex 94 72%
Age (years) 94 67.5 (8.2) 68.2 40 83
PEF (l/min) 94 224 (79) 220 60 453
FEV1 (ml) 28 967 (363) 880 355 1731
FVC (ml) 28 1952 (762) 2010 690 3782
Reversibility 91 6.5 (10.2) 5.3 -31 37
Mean no. of large PEF
decrements*
94 14 (26) 2.5 0 122
Mean no. of exacerbations 94 3.1 (3.2) 2 0 16
Mean no. of symptomatic
falls in PEFy
94 3.7 (3.7) 2.5 0 16
Mean no. of episodes of
dyspnoeaz
94 5.7 (5.4) 3.5 0 20
Mean no. of episodes of
change in sputumx
94 2.9 (3.4) 2 0 17
Mean no. of episodes
of nasal discharge/
congestion
94 2.9 (3.6) 2 0 19
Mean no. of episodes
of wheeze{
94 3.8 (4.5) 2 0 18
Mean no. of episodes
of URS**
94 2.7 (3.0) 2 0 14
*Large PEF decrements: PEF <20% 3 median value.
ySymptomatic fall in PEFs: defined as fall in PEF 10 l/min for $2 days + increase in
breathlessness.
zDyspnoea: defined as an increase in symptom.
xSputum changes: defined as a change in sputum purulence or amount.
{Wheeze: defined as an increase in wheeze or increase in tightness of chest.
**URS: upper respiratory symptomsdincrease in sore throat or cough.
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; PEF, peak expiratory flow.








[median] IQR Mean Range Mean Range
NO2 (1 h max, ppb) 51.4 (15.8),
[48], 42 to 56
51.3 26 to 163 51.5 24 to 131
O3 (8 h ave, ppb) 15.5 (10.7),
[14.1], 7.5 to 21.6
9.8 1 to 32 21.6 3 to 74
SO2 (24 h ave, ppb) 7.5 (6.3),
[5.3], 3.2 to 9.3
9.8 1 to 42 5.5 1 to 74
PM10 (24 h ave, mg/m
3) 37.7 (17.4),
[32.5], 25.9 to 44.9
39.1 10 to 134 35.6 13 to 86
Black smoke*
(24 h ave, mg/m3)
10.1 (9.7),
[7], 4 to 13
12.9 1 to 81 7.0 1 to 34
Outdoor temperature
(average of min and
max, oC)
11.4 (6.0),
[11], 1.5 to 27
8.1 1.5 to 21 15.3 4.5 to 27
*Summary statistics presented for the Stepney black smoke monitor used for 63% of
patients.
PM, particulate matter.
Table 3 Regression of respiratory function (PEF, FEV1 and FVC) on
pollutant level* (previous day)
Estimatey (per unit




NO2 (ppb) 0.013 (0.002 to 0.024) 0.026 0.179
O3 (ppb) 0.015 (0.039 to 0.009) 0.229 0.211
SO2 (ppb) 0.031 (0.010 to 0.072) 0.133 0.191
PM10 (mg/m
3) 0.009 (0.006 to 0.023) 0.253 0.164
Black smoke (mg/m3) 0.011 (0.005 to 0.028) 0.180 0.103
FEV1 (ml) n¼28
NO2 (ppb) 0.005 (0.106 to 0.116) 0.929 0.071
O3 (ppb) 0.081 (0.258 to 0.096) 0.369 1.143
SO2 (ppb) 0.035 (0.386 to 0.315) 0.843 0.216
PM10 (mg/m
3) 0.031 (0.067 to 0.129) 0.536 0.588
Black smoke (mg/m3) 0.045 (0.113 to 0.203) 0.576 0.405
FVC (ml) n¼28
NO2 (ppb) 0.071 (0.189 to 0.332) 0.591 1.000
O3 (ppb) 0.162 (0.238 to 0.562) 0.426 2.288
SO2 (ppb) 0.335 (1.192 to 0.522) 0.444 2.043
PM10 (mg/m
3) 0.187 (0.017 to 0.392) 0.073 3.561
Black smoke (mg/m3) 0.166 (0.218 to 0.551) 0.396 1.498
*In addition to individual pollutants (previous day), each model includes outdoor
temperature (average of the minimum and maximum) and season (four categories) plus
control for autocorrelation.
yEstimates represent the change in lung function for a 1 unit change in pollutant level (ppb
for NO2, O3, SO2; mg/m
3 for PM10, black smoke).
zEstimates represent the change in lung function for an IQR change in pollutant level.
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; PEF, peak expiratory flow;
PM, particulate matter.
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1.13; 95% CI 1.04 to 1.23) for a rise in PM10 across its IQR. No
other symptomepollutant combinations were signiﬁcant,
except O3 which showed a protective association with nasal
discharge/congestion (table 5).
In multipollutant models, the effect size for PM10 on symp-
tomatic fall in PEF remained similar and borderline signiﬁcant
after adjustment for other pollutants (table 6). In contrast, the
effects of NO2 and black smoke were weaker after controlling
for PM10. For dyspnoea, the effect of PM10 was slightly stronger
and remained signiﬁcant after adjustment for either NO2, black
smoke or both (table 6). There was no evidence of any adverse
effect of NO2 or black smoke after allowing for PM10.
DISCUSSION
Overall this study provided evidence for adverse effects of
outdoor pollution on symptoms and exacerbations in patients
with COPD living in London, particularly PM10, black smoke
and NO2. Most symptoms gave ORs >1 but very few associa-
tions were statistically signiﬁcant. Effect sizes were mostly
larger for symptomatic fall in PEF compared with COPD exac-
erbations and gave signiﬁcant ORs for NO2, PM10 and black
smoke. Symptomatic falls in PEF events were more common
than COPD exacerbations and so signiﬁcance is partly due to
increased statistical power. Dyspnoea was associated with
higher levels of PM10 but was not signiﬁcantly associated
with any other pollutants. Multiple pollutant models showed
that the association between PM10 and dyspnoea was stronger
after adjustment for other pollutants, although this analysis was
post hoc and conducted to aid interpretation of the ﬁndings. In
general, symptoms are highly variable in COPD and the
appearance of shortness of breath on the diary card may reﬂect
psychological as well as mechanical effects on the airway. The
occurrence of shortness of breath with a fall in PEF is suggestive
of a mechanical effect on the airway by some stimulus.
When estimated effect sizes were scaled to IQR increases in
pollutant level, it was evident that estimated effect sizes were
considerable: the odds of a symptomatic fall in PEF increased by
13% when PM10 increased across the IQR, and a similar size
effect was observed for dyspnoea. These increases in odds
represent a substantial increase in risk, if associations were real
and causal, and are stronger than observed effects of raised
pollution on COPD hospital admissions.5
Effects on neither mean lung function nor the binary large PEF
decrements showed consistent trends, despite evidence from
other panels that the binary outcome is more discriminating
than mean PEF.8 24 This may reﬂect the high variability of PEF
and/or that lung function was measured after taking medica-
tion. Importantly, the ﬁndings of adverse effects on symptoms
but not mean lung function are consistent with results of
ecological studies showing associations with acute events such
as death, hospital admission and general practitioner consulta-
tions. They lend support to the hypothesis that effects of
outdoor air pollution are greater among the very vulnerable.
Findings in this London study were consistent with those of
Harré in New Zealand11 who reported associations between
particles and symptoms with similar effect sizes to ours;
however, they also found no associations with lung function.








NO2 (ppb) 1.000 (0.995 to 1.004) 0.844 0.994
O3 (ppb) 0.996 (0.989 to 1.004) 0.362 0.950
SO2 (ppb) 1.001 (0.988 to 1.014) 0.890 1.006
PM10 (mg/m
3) 0.999 (0.995 to 1.003) 0.712 0.985
Black smoke (mg/m3) 1.001 (0.991 to 1.011) 0.851 1.009
COPD exacerbations
NO2 (ppb) 1.002 (0.996 to 1.008) 0.469 1.032
O3 (ppb) 1.005 (0.987 to 1.023) 0.598 1.070
SO2 (ppb) 1.002 (0.982 to 1.022) 0.878 1.010
PM10 (mg/m
3) 1.004 (0.998 to 1.010) 0.234 1.075
Black smoke (mg/m3) 1.003 (0.994 to 1.013) 0.497 1.029
Symptomatic fall in PEF
NO2 (ppb) 1.004 (0.999 to 1.009) 0.137 1.058
O3 (ppb) 1.002 (0.984 to 1.020) 0.840 1.026
SO2 (ppb) 1.004 (0.987 to 1.022) 0.622 1.026
PM10 (mg/m
3) 1.006 (1.001 to 1.012) 0.029 1.124
Black smoke (mg/m3) 1.007 (1.000 to 1.014) 0.050 1.066
*In addition to individual pollutants (previous day), each model includes outdoor
temperature (average of the minimum and maximum) and season (four categories) plus
control for autocorrelation.
yORs are for a 1 unit change in pollutant level (ppb for NO2, O3, SO2; mg/m3 for PM10, black
smoke).
zORs are for an IQR change in pollutant level.
COPD, chronic obstructive pulmonary disease; PEF, peak expiratory flow; PM, particulate
matter.
Table 5 Worsening symptoms: dyspnoea, sputum purulence or








NO2 (ppb) 1.003 (0.997 to 1.008) 0.338 1.036
O3 (ppb) 1.005 (0.995 to 1.016) 0.335 1.078
SO2 (ppb) 0.996 (0.980 to 1.013) 0.662 0.978
PM10 (mg/m
3) 1.006 (1.002 to 1.011) 0.008 1.125
Black smoke (mg/m3) 1.003 (0.994 to 1.012) 0.526 1.027
Sputum changes n¼68
NO2 (ppb) 1.006 (0.999 to 1.013) 0.085 1.085
O3 (ppb) 1.007 (0.992 to 1.022) 0.370 1.099
SO2 (ppb) 1.008 (0.988 to 1.029) 0.446 1.042
PM10 (mg/m
3) 1.004 (0.997 to 1.011) 0.251 1.082
Black smoke (mg/m3) 1.004 (0.992 to 1.016) 0.536 1.035
Nasal discharge or congestion n¼70
NO2 (ppb) 0.999 (0.991 to 1.006) 0.690 0.979
O3 (ppb) 0.984 (0.970 to 0.998) 0.023 0.794
SO2 (ppb) 1.011 (0.994 to 1.030) 0.209 1.072
PM10 (mg/m
3) 1.003 (0.997 to 1.010) 0.296 1.067
Black smoke (mg/m3) 1.003 (0.992 to 1.013) 0.598 1.026
Wheeze or tight chest n¼70
NO2 (ppb) 1.002 (0.996 to 1.009) 0.460 1.033
O3 (ppb) 0.992 (0.977 to 1.007) 0.274 0.890
SO2 (ppb) 1.002 (0.986 to 1.019) 0.785 1.014
PM10 (mg/m
3) 1.004 (0.998 to 1.009) 0.187 1.071
Black smoke (mg/m3) 1.002 (0.993 to 1.010) 0.722 1.014
Upper respiratory symptoms n¼73
NO2 (ppb) 0.999 (0.990 to 1.008) 0.849 0.988
O3 (ppb) 0.987 (0.969 to 1.005) 0.143 0.829
SO2 (ppb) 0.991 (0.971 to 1.012) 0.392 0.947
PM10 (mg/m
3) 1.000 (0.993 to 1.007) 0.928 0.994
Black smoke (mg/m3) 1.007 (0.990 to 1.024) 0.435 1.062
*In addition to individual pollutants (previous day), each model includes outdoor
temperature (average of the minimum and maximum) and season (four categories) plus
control for autocorrelation.
yORs are for a 1 unit change in pollutant level (ppb for NO2, O3, SO2; mg/m3 for PM10, black
smoke).
zORs are for an IQR change in pollutant level.
PM, particulate matter.
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Trenga10 reported effects of PM2.5 on FEV1 in all adults but no
effects on PEF. PM2.5 data were not available when our study
was conducted but since PM10 is dominated by small particles,
the comparison with our study is reasonable. The adverse effects
of O3 on exacerbations demonstrated in the Parisian study12
were stronger than in our study.
The estimated relationships between air pollution and
symptoms and lung function in this COPD panel may have been
affected by the time patients spent outdoors. Subjects recorded
this for part of the study only and so, although we did adjust,
full adjustment was not possible.
When this study was designed we chose to limit the use of
multiple pollutant metrics to avoid overtesting. In particular we
used just one measure for NO2d1 h maximumdpartly because
of the belief that the peak drives health effects. However, the
correlation between 1 h maximum NO2 and average daily NO2
was very high at 0.90, and so the choice would seem unlikely to
matter. When our study was conducted, there was a network of
black smoke monitors and so we used the monitor nearest to the
patient’s home to estimate their exposure. The data on the other
pollutants all came from a single monitor in central London but
the correlation with another monitor for PM10 was high (0.95),
suggesting that this was not unreasonable. Even so, the use of
multiple monitors may explain the weaker associations observed
with black smoke. We modelled exposure to pollution using
previous day pollutant level as others have done, and have not
looked at long lags25 which would most probably have produced
stronger associations.
Daily diary data provide a powerful tool tool to investigate
effects of air pollution within individuals but are resource
intensive and often panels are only able to include a relatively
small sample and/or a short follow-up time. The strength of this
study was the relatively large sample, 94, and the lengthy 2-year
follow-up period. Since compliance was very good, missing data
were minimal.
Recent WHO guidelines for PM10 are 20 and 50 mg/m3 for annual
and daily averages, respectively. The levels of exposure for this panel
were a little higher. The WHO guidelines were largely based on
ecological time series studies and cohort data on mortality. This
study therefore lends support to the guideline.
In conclusion, in patients with COPD living in London, there
is evidence for adverse effects of outdoor pollution on symptoms
and exacerbations, particularly for PM10, black smoke and NO2.
The ORs of up to 1.17 for an IQR increase in pollutant level
represent substantial effects which would have important public
health implications if shown to be real and causal. This deserves
further investigation in larger panels.
Funding The East London COPD study was funded by the British Lung Foundation. The
statistical analysis for the air pollution analyses was funded by the UK Department of
Health.
Table 6 Further investigation of associations with PEF exacerbations and dyspnoea: single and multiple
pollutant models*
Model*
Single pollutant models Multiple pollutant models
ORy
(unit change) SE p Value
ORy
(unit change) SE p Value
ORz
(IQR change)
Symptomatic fall in PEF (N¼78)
Model 1
NO2 1.004 0.003 0.137 0.999 0.003 0.709 0.983
PM10 1.006 0.003 0.029 1.007 0.003 0.042 1.140
Model 2
NO2 1.004 0.003 0.137 1.002 0.004 0.654 1.025
Black smoke 1.007 0.004 0.050 1.005 0.005 0.306 1.049
Model 3
PM10 1.006 0.003 0.029 1.006 0.004 0.083 1.126
Black smoke 1.007 0.004 0.050 1.000 0.005 0.953 0.998
Model 4
NO2 1.004 0.003 0.137 0.999 0.004 0.725 0.980
PM10 1.006 0.003 0.029 1.007 0.004 0.064 1.137
Black smoke 1.007 0.004 0.050 1.001 0.006 0.907 1.006
Dyspnoea n¼77
Model 1
NO2 1.003 0.003 0.338 0.997 0.003 0.380 1.017
PM10 1.006 0.002 0.008 1.008 0.003 0.007 1.031
Model 2
NO2 1.003 0.003 0.338 1.001 0.004 0.760 0.961
Black smoke 1.003 0.005 0.526 1.003 0.006 0.598 1.159
Model 3
PM10 1.006 0.002 0.008 1.008 0.003 0.007 1.156
Black smoke 1.003 0.005 0.526 0.996 0.006 0.455 0.961
Model 4
NO2 1.003 0.003 0.338 0.998 0.004 0.578 0.970
PM10 1.006 0.002 0.008 1.008 0.003 0.005 1.168
Black smoke 1.003 0.005 0.526 0.998 0.007 0.733 0.979
*In addition to individual pollutants (previous day), each model includes outdoor temperature (average of the min and maximum) and
season (four categories) plus control for autocorrelation. Models 1e3 each contain two pollutants analysed together. Model 4 includes
all three pollutants.
yORs are for a 1 unit change in pollution level (ppb for NO2, O3, SO2; mg/m3 for PM10, black smoke).
zORs are for an IQR change in pollutant level.
PEF, peak expiratory flow; PM, particulate matter.
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